Infinity Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals

INFI 0.0160

-4.8%

Sep 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dr.praveen who wrote (24)	4/24/2006 4:03:55 PM
From: Mike McFarland	of 210

So, if Wall Street is going to initially give them something on the order of a marketcap 200M, INFI will be trading at about the same level as DPII is now (the 0.95 conversion seems not to mean too much). A three for one reverse split might not be a bad idea to get the shares up around $7 or $8 a share to start, bring the number of shares right back down to 27M. Arqule and Infinity will be an interesting horse race in the years ahead. Arguably, Arqule at MC 200M looks undervalued against an Infinity at 200M. arqule.com (this was pointed out over on Yahoo. It sure makes me squirm to admit those guys could be right) Probably it makes sense to see them race for a good five years. I suppose we may see INFI shares start out slow the way things have gone so far for dpii.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next